On Day 2 of the Clinical Trials Technology Congress 2026, the opening keynote explored how technology, real-time data and AI are transforming clinical development; enabling organisations to deliver smarter, more efficient clinical trials at scale.

Moderator & Speakers

• Nicholas Lakin, Executive Managing Director, Syneos Health Consulting
• Astrid Scherer, Head of Product Development and Process Excellence Clinical Development (VP), Bayer Pharmaceuticals
• Rebecca Jackson, Associate Director, Global Development Systems, Johnson & Johnson
• Raja Shankar, Vice President, Machine Learning, AI & Technology Solutions, IQVIA

To watch the talks and discussion please register below.